Interactive Investor
>>

Medlab Clinical Ltd (ASX:MDC) Share Price

MDC

Medlab Clinical Ltd

APAC company

Right Arrow 1

Healthcare

Right Arrow 2

Biotechnology

Bid

-

Ask

-

Last Traded

-

Chg

-

-

XASX

-

Updated: -

Research

News & analysis

Loading...

Times are shown in GMT+10, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.

Company Profile

Medlab Clinical Ltd is a medical research and development company. It is engaged in researching and formulating novel biotherapeutics to improve health outcomes in early to moderate stage chronic diseases such as chronic kidney disease, pre-diabetes, and obesity. Some of the company's nutraceutical products are Multibiotic, Mg Optima Relax, NRGBiotic, NanoCelle D3, SB 5B and others. The principal segments of the group are Nutraceutical which includes the sale of nutraceutical products; and Pharmaceutical research. It generates the majority of the revenue from the sale of nutraceutical products. The business operations of the firm are carried out from Australia.Medlab Clinical Ltd is an Australia-based medical research and development company. The principal activities of the group are the sale of nutraceutical products and pharmaceutical research.

ASX:MDC

AU000000MDC8

AUD

Loading...

Loading Comparison

Latest MDC News